KatGuide Method Versus Conventional Method at Insertion of Chest Tube (KatGuide)

August 19, 2014 updated by: Niels Katballe

KatGuide-trial. KatGuide Method Versus Conventional Method at Insertion of Chest Tube. A Randomized, Parallel Group, Controlled Trial.

The purpose of this study is to investigate whether if KatGuide (a new developed medical device) improves the placing of a large bore chest tube in the pleural cavity compared to the conventional method.

Study Overview

Study Type

Interventional

Enrollment (Actual)

109

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aalborg, Denmark, 9000
        • Vytautas Nekrasas
      • Aarhus N, Denmark, 8200
        • Niels Katballe
      • Odense, Denmark, 5000
        • Peter B Licht
    • Aarhus N
      • Aarhus, Aarhus N, Denmark, 8200
        • Niels Katballe

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with pneumothorax in the upper pleural space or fluid in the lower pleural space.
  • Indication for upper or lower placement of a single chest tube in the pleural cavity
  • 18 years of age or older

Exclusion Criteria:

  • Fertile women
  • Patients who can not give written or verbal consent to participate
  • If there is no time or possibility to inform the patient
  • Patients who already has a large bore chest tube
  • Patients with long lasting (>14 days) or chronic chest tube
  • Patients with both fluid and air in the pleural cavity
  • Patients where "the safe area" (front axillary fold, IC 4-5) can not be used for chest tube insertion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: KatGuide
Chest tube insertion is performed by using the KatGuide
According to randomization Chest tubes are placed in the pleural cavity by using the KatGuide device.
ACTIVE_COMPARATOR: Conventional group
Chest tubes are inserted by using conventional method (forceps) for large bore chest tube insertion.
The chest tube is placed in the pleural cavity by using a forceps (conventional method) or KatGuide

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chest tube placement
Time Frame: 3 hours
X-ray examination of the chest is performed within 3 hours after the chest tube insertion, to evaluate if the placement of the chest tube is acceptable.
3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of hospital stay
Time Frame: 5 days
The hospital stay depends on how long time it takes to solve the chest tube related problem. In a few patients it takes only one day, but in severe cases it may take weeks before the patient can be discharged. We predict, that the patient will be in hospital for a mean time of 5 days.
5 days
Time with chest tube
Time Frame: 3 days (mean time)
A few patients can have the chest tube removed in only one day, but some patients must have a chest tube for weeks. We predict that the patients will have a chest tube in a mean time of 3 days.
3 days (mean time)
Infection in wound
Time Frame: 4 weeks
4 weeks after the chest tube insertion, the patient is contacted and the patient is asked whether there are problems with infection of the wound.
4 weeks
Number of chest tubes
Time Frame: 7 days (mean time)
It is observed whether the patient has multiple chest tubes inserted in the pleural cavity at the same side. It is predicted, that these patients are hospitalized longer than patients with only one chest tube. We predict, that these patients are hospitalized for a mean time of 7 days.
7 days (mean time)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Study Director: Niels Katballe, MD, PhD, University of Aarhus

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (ACTUAL)

May 1, 2014

Study Completion (ACTUAL)

May 1, 2014

Study Registration Dates

First Submitted

January 24, 2012

First Submitted That Met QC Criteria

January 27, 2012

First Posted (ESTIMATE)

February 1, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

August 21, 2014

Last Update Submitted That Met QC Criteria

August 19, 2014

Last Verified

August 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumothorax

Clinical Trials on KatGuide versus conventional method (forceps)

3
Subscribe